Composite Resources, Inc. v. Parsons: Tourniquet Patent Appeal Dismissed
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Composite Resources, Inc. v. Derek R. Parsons |
| Case Number | 23-1547 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District of Columbia |
| Duration | March 1, 2023 – April 5, 2024 401 days |
| Outcome | Voluntary Dismissal |
| Patents at Issue | |
| Accused Products | Tourniquet and Method of Use |
Case Overview
The Parties
⚖️ Plaintiff
A company asserting rights over a portfolio of tourniquet-related patents, operating in defense, emergency response, and clinical markets.
🛡️ Defendant
The named individual defendant, potentially involved in inventor-ownership conflicts or independent commercialization of competing tourniquet products.
The Patents at Issue
Four U.S. patents were asserted in this litigation, covering tourniquet devices and their methods of use. These technologies encompass mechanical compression systems, strap mechanisms, windlass components, and clinical application procedures central to hemorrhage control.
- • U.S. Patent No. 7,842,067 (Application No. 11/147,806)
- • U.S. Patent No. 8,888,807 (Application No. 12/954,574)
- • U.S. Patent No. 3,863,064 (Application No. 05/214,617)
- • U.S. Patent No. 7,892,253 (Application No. 11/846,382)
Designing a similar medical device?
Check if your tourniquet technology might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The appeal was voluntarily dismissed pursuant to Federal Rule of Appellate Procedure 42(b), with each party bearing their own costs. No damages were awarded, and no injunctive relief was granted or denied at this stage. No substantive ruling on patent validity or infringement was issued by the Federal Circuit.
Key Legal Issues
The absence of a merits-based opinion from the Federal Circuit is itself legally significant, as it means no precedential ruling was generated. The decision to voluntarily dismiss at the appellate level reflects a sophisticated risk-reward analysis by both parties, likely involving a settlement or strategic recalculation. The mutual cost-bearing arrangement is a hallmark of a negotiated resolution rather than a capitulation by either side.
Pursuing infringement claims against an individual defendant creates unique strategic and practical considerations, including collectability of any judgment and the defendant’s capacity to sustain prolonged litigation — all factors that can accelerate settlement discussions.
Freedom to Operate (FTO) Analysis in Medical Devices
This case highlights critical IP risks in tourniquet technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in medical emergency equipment
- See which companies are most active in tourniquet patents
- Understand claim construction patterns for device & method claims
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Tourniquet devices and methods of use
4 Patents at Issue
Covering both device and methods
Strategic Design-Around
Crucial for market entry
✅ Key Takeaways
Voluntary Federal Circuit dismissal under Rule 42(b) generates no precedent — merits remain unresolved on the public record.
Search related case law →Mutual cost-bearing in appellate dismissals signals negotiated resolution, not unilateral capitulation.
Explore legal strategies →Individual defendants in patent cases create unique strategic dynamics affecting both litigation conduct and settlement leverage.
Understand defendant dynamics →Medical device IP portfolios combining device and method claims require comprehensive design-around strategies addressing both dimensions.
Start FTO analysis for my product →Assess supplier and design partner relationships for potential patent exposure in emergency medical equipment development.
Try AI patent drafting →The case’s 401-day appellate arc suggests early-stage negotiations may have commenced during briefing, emphasizing prompt resolution strategies.
Explore negotiation tactics →Frequently Asked Questions
Four U.S. patents: No. 7,842,067; No. 8,888,807; No. 3,863,064; and No. 7,892,253, all covering tourniquet devices and methods of use.
The parties jointly agreed to voluntary dismissal under Fed. R. App. P. 42(b), with each side bearing their own costs — no merits ruling was issued.
The unresolved appellate record leaves claim validity and infringement questions open, meaning the asserted patents remain active enforcement tools without Federal Circuit-level validation or invalidation.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- United States Court of Appeals for the Federal Circuit — Case 23-1547
- U.S. Patent and Trademark Office — Patent Full-Text Database
- Cornell Legal Information Institute — Federal Rule of Appellate Procedure 42(b)
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Product?
Don’t wait for litigation. Check your medical device’s freedom to operate now with AI-powered analysis.
Run FTO for My Product